Lisa Kattan, Co-Chair of the firm’s International Trade Commission (ITC) Practice, represents technology and life sciences clients in patent litigation, particularly in section 337 investigations before the ITC and related district court, appellate, and US Customs and Border Protection proceedings.
Lisa draws on more than two decades of trial experience to advise clients on complex, multi-faceted disputes spanning technologies including:
Before joining Latham, Lisa chaired the ITC litigation practice group at another global law firm. Prior to that, she was a senior investigative attorney in the ITC’s Office of Unfair Import Investigations.
Lisa is a Chambers USA and Legal 500 US-ranked ITC practitioner and a member of the ITC Trial Lawyers Association. She is a frequent speaker about ITC litigation strategy and best practices.
Lisa’s ITC career began with Certain Modified Vaccinia Ankara and Vaccines and Pharmaceutical Compositions, ITC Inv. 337-TA-550. Prior to returning to private practice, she was lead counsel for the government on a variety of telecommunications, medical device, and consumer device 337 investigations.
Lisa’s client representations prior to joining Latham include: